Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform-Reference-Cited by-同舟云学术

Respiratory Syncytial Virus Fusion Protein-encoding DNA Vaccine Is Less Effective in Conferring Protection against Inflammatory Disease than a Virus-like Particle Platform

Published:2019 Issue:3 Volume:19 Page:
ISSN:1598-2629
Container-title:Immune Network
language:en
Short-container-title:Immune Netw

Author:

Kwon Young-Man¹,Hwang Hye Suk¹²,Lee Young-Tae¹³,Kim Ki-Hye¹,Lee Youri¹,Kim Min-Chul¹⁴,Lee Yu-Na¹⁵,Quan Fu-Shi¹⁶,Moore Martin L.⁷,Kang Sang-Moo¹^ORCID

Affiliation:

1. Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.

2. Department of Microbiology, Chonnam National University Medical School, Hwasun 58128, Korea.

3. Green Cross Cell Corp., Yongin 16924, Korea.

4. Komipharm Co., Ltd., Siheung 15094, Korea.

5. Animal and Plant Quarantine Agency, Gimcheon 39660, Korea.

6. Department of Medical Zoology, Kyung Hee University School of Medicine, Seoul 02447, Korea.

7. Meissa Vaccines, South San Francisco, CA 94080, USA.

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

The Korean Association of Immunobiologists

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Link

https://synapse.koreamed.org/pdf/10.4110/in.2019.19.e18

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laser-assisted intradermal delivery of a microparticle vaccine for respiratory syncytial virus induces a robust immune response;Vaccine;2023-02

2. Respiratory Viruses and Virus-like Particle Vaccine Development: How Far Have We Advanced?;Viruses;2023-01-30

3. Natural Killer and CD8 T Cells Contribute to Protection by Formalin Inactivated Respiratory Syncytial Virus Vaccination under a CD4-Deficient Condition;Immune Network;2020

4. Respiratory syntycial virus: Current treatment strategies and vaccine approaches;Antiviral Chemistry and Chemotherapy;2020-01

5. Vaccines against human respiratory syncytial virus in clinical trials, where are we now?;Expert Review of Vaccines;2019-10-03